ASHLEY OLSZEWSKI: Open Payments
NPI 1396462859 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 11 payments from 6 companies in 2025. Trend: 2023 $253 · 2024 $183 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 6 | $120 |
| Astellas Pharma US Inc | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| MILLICENT US INC | 1 | $14 |
| Organon LLC | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
Products named: Veozah, JOURNAVX, INTRAROSA, NEXPLANON, Fluad.
Industry payments across MD — which companies pay providers there.
